These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17785447)

  • 1. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
    Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
    Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
    Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
    Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
    Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anchorage-independent phosphorylation of p130(Cas) protects lung adenocarcinoma cells from anoikis.
    Wei L; Yang Y; Zhang X; Yu Q
    J Cell Biochem; 2002; 87(4):439-49. PubMed ID: 12397603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
    Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
    Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src.
    Sakuma Y; Takeuchi T; Nakamura Y; Yoshihara M; Matsukuma S; Nakayama H; Ohgane N; Yokose T; Kameda Y; Tsuchiya E; Miyagi Y
    J Pathol; 2010 Apr; 220(5):574-85. PubMed ID: 20146241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.
    Uekita T; Fujii S; Miyazawa Y; Iwakawa R; Narisawa-Saito M; Nakashima K; Tsuta K; Tsuda H; Kiyono T; Yokota J; Sakai R
    Mol Cancer Res; 2014 Oct; 12(10):1449-59. PubMed ID: 24939643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine kinase-dependent, phosphatidylinositol 3'-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis.
    Wei L; Yang Y; Yu Q
    Cancer Res; 2001 Mar; 61(6):2439-44. PubMed ID: 11289112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis.
    Wei L; Yang Y; Zhang X; Yu Q
    Oncogene; 2004 Dec; 23(56):9052-61. PubMed ID: 15489898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
    Uekita T; Sakai R
    Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.
    Gandji LY; Proust R; Larue L; Gesbert F
    PLoS One; 2015; 10(4):e0123472. PubMed ID: 25876044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
    Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
    Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.
    Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S
    Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.
    Seidel J; Kunc K; Possinger K; Jehn C; Lüftner D
    Biochem Biophys Res Commun; 2011 Oct; 414(1):226-32. PubMed ID: 21945930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
    Benes CH; Poulogiannis G; Cantley LC; Soltoff SP
    Oncogene; 2012 Feb; 31(5):653-63. PubMed ID: 21725358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.
    Wortmann A; He Y; Christensen ME; Linn M; Lumley JW; Pollock PM; Waterhouse NJ; Hooper JD
    J Biol Chem; 2011 Dec; 286(49):42303-42315. PubMed ID: 21994943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connexin 32 expression reduces malignant phenotype in human A549 adenocarcinoma cells: Implication of Src involvement.
    Hada S; Sato H; Virgona N; Hagiwara H; Saito T; Suzuki K; Asano R; Yano T
    Oncol Rep; 2006 Nov; 16(5):1149-54. PubMed ID: 17016607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
    Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.
    Cao M; Gao J; Zhou H; Huang J; You A; Guo Z; Fang F; Zhang W; Song T; Zhang T
    Tumour Biol; 2016 Feb; 37(2):1651-62. PubMed ID: 26307391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hp95 promotes anoikis and inhibits tumorigenicity of HeLa cells.
    Wu Y; Pan S; Luo W; Lin SH; Kuang J
    Oncogene; 2002 Oct; 21(44):6801-8. PubMed ID: 12360406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.